Literature DB >> 28478437

Alterations in Glucose Effectiveness and Insulin Dynamics: Polycystic Ovary Syndrome or Body Mass Index.

Patricia Vuguin1, Aviva B Sopher1, Hailey Roumimper1, Vivian Chin1, Miriam Silfen1, Donald J McMahon2, Ilene Fennoy1, Sharon E Oberfield1.   

Abstract

BACKGROUND/AIMS: To delineate the relationship of polycystic ovary syndrome (PCOS), obesity, and hyperandrogenism (HA) with glucose and insulin dynamics in adolescents across a broad body mass index (BMI).
METHODS: Seventy-four PCOS subjects (aged 16 years) and 82 controls (aged 16 years) were evaluated by an oral glucose tolerance test. Subjects were categorized by BMI: normal weight (21 ± 0.4), overweight/obesity (OO; 33 ± 1.0), and severe obesity (SO; 48 ± 1.4). Indices of glucose and insulin dynamics were determined. Multiple linear regression analysis was used to evaluate the contribution of PCOS, HA, and BMI to these indices.
RESULTS: BMI was significantly associated with systolic and diastolic blood pressure and insulin resistance. A significant interaction between BMI and PCOS and indices of post-glucose load was observed. The mean difference in peak glucose, early glucose response, area under the curve for glucose, and glucose effectiveness (SgIo) between PCOS and control subjects was significantly different between OO and SO. In PCOS subjects, testosterone was positively associated with BMI, fasting insulin, early insulin response, and diastolic blood pressure, and negatively associated with SgIo.
CONCLUSIONS: Abnormal glucose dynamics in adolescents with PCOS is mainly due to SO. The combination of PCOS and SO has a synergistic effect on glucose dynamics when compared to all other groups.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Glucose effectiveness; Insulin resistance; Metabolic dysregulation; Metabolic syndrome; Polycystic ovary syndrome in adolescents

Mesh:

Substances:

Year:  2017        PMID: 28478437      PMCID: PMC5914159          DOI: 10.1159/000471804

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  35 in total

1.  Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome.

Authors:  Mark R Palmert; Catherine M Gordon; Alex I Kartashov; Richard S Legro; S Jean Emans; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

2.  Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.

Authors:  Ramin Alemzadeh; Jessica Kichler; Mariaelena Calhoun
Journal:  Eur J Endocrinol       Date:  2010-04-06       Impact factor: 6.664

3.  Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.

Authors:  Andrea D Coviello; Richard S Legro; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2005-10-25       Impact factor: 5.958

4.  Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome.

Authors:  Roger Hart; Dorota A Doherty; Trevor Mori; Rae-Chi Huang; Robert J Norman; Stephen Franks; Deborah Sloboda; Lawrie Beilin; Martha Hickey
Journal:  Fertil Steril       Date:  2011-03-29       Impact factor: 7.329

5.  Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome.

Authors:  Mei-Jou Chen; Wei-Shiung Yang; Jehn-Hsiahn Yang; Chi-Ling Chen; Hong-Nerng Ho; Yu-Shih Yang
Journal:  Hypertension       Date:  2007-03-26       Impact factor: 10.190

Review 6.  Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Lisa J Moran; Marie L Misso; Robert A Wild; Robert J Norman
Journal:  Hum Reprod Update       Date:  2010-02-16       Impact factor: 15.610

7.  Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.

Authors:  Miriam E Silfen; Michelle R Denburg; Alexandra M Manibo; Rogerio A Lobo; Richard Jaffe; Michel Ferin; Lenore S Levine; Sharon E Oberfield
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

8.  Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.

Authors:  M M Ollila; S West; S Keinänen-Kiukaanniemi; J Jokelainen; J Auvinen; K Puukka; A Ruokonen; M-R Järvelin; J S Tapanainen; S Franks; T T Piltonen; L C Morin-Papunen
Journal:  Hum Reprod       Date:  2016-12-28       Impact factor: 6.918

9.  Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

Authors:  Bart C J M Fauser; Basil C Tarlatzis; Robert W Rebar; Richard S Legro; Adam H Balen; Roger Lobo; Enrico Carmina; Jeffrey Chang; Bulent O Yildiz; Joop S E Laven; Jacky Boivin; Felice Petraglia; C N Wijeyeratne; Robert J Norman; Andrea Dunaif; Stephen Franks; Robert A Wild; Daniel Dumesic; Kurt Barnhart
Journal:  Fertil Steril       Date:  2011-12-06       Impact factor: 7.329

10.  Insulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass index.

Authors:  Melania Manco; Lidia Castagneto-Gissey; Eugenio Arrighi; Annamaria Carnicelli; Claudia Brufani; Rosa Luciano; Geltrude Mingrone
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

View more
  1 in total

1.  Assessing the predictive accuracy of oral glucose effectiveness index using a calibration model.

Authors:  Michael Glicksman; Shivraj Grewal; Shrayus Sortur; Brent S Abel; Sungyoung Auh; Trudy R Gaillard; Kwame Osei; Ranganath Muniyappa
Journal:  Endocrine       Date:  2018-11-06       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.